Institut National de la Santé et de la Recherche Médicale, Unité 1013, Paris 75015, France.
Cell Mol Life Sci. 2011 May;68(9):1553-67. doi: 10.1007/s00018-011-0662-1. Epub 2011 Mar 10.
Peptide ligands presented by MHC class I molecules are produced by intracellular proteolysis, which often involves multiple steps. Initial antigen degradation seems to rely almost invariably on the proteasome, although tripeptidyl peptidase II (TPP II) and insulin-degrading enzyme (IDE) may be able to substitute for the proteasome in rare cases. Recent evidence suggests that the net effect of cytosolic aminopeptidases is destruction of potential class I ligands, although a positive role in selected cases has been documented. This may apply particularly to the trimming of long precursors by TPP II. In contrast, trimming of ligand precursors in the endoplasmic reticulum is essential for the generation of suitable peptides and has a substantial impact on the repertoire of ligands presented. Trimming by the ER aminopeptidase (ERAP) enzymes most likely acts on free precursors and is adapted to the needs of class I molecules by way of a molecular ruler mechanism. Trimming by ERAP enzymes also occurs for cross-presented ligands, which can alternatively be processed in a special endosomal compartment by insulin-regulated aminopeptidase.
MHC I 类分子呈递的肽配体是通过细胞内蛋白水解产生的,这通常涉及多个步骤。初始抗原降解似乎几乎总是依赖蛋白酶体,尽管三肽基肽酶 II(TPP II)和胰岛素降解酶(IDE)在极少数情况下可能能够替代蛋白酶体。最近的证据表明,胞质氨肽酶的净效应是破坏潜在的 I 类配体,尽管在某些情况下已经证明了它们的积极作用。这可能特别适用于 TPP II 对长前体的修剪。相比之下,内质网中配体前体的修剪对于产生合适的肽至关重要,并且对呈递的配体谱具有重大影响。内质网氨肽酶 (ERAP) 酶的修剪很可能作用于游离前体,并通过分子尺机制适应 I 类分子的需求。ERAP 酶也会对交叉呈递的配体进行修剪,这些配体也可以通过胰岛素调节的氨肽酶在特殊的内体隔室中进行加工。